1. Home
  2. PANW vs MRK Comparison

PANW vs MRK Comparison

Compare PANW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palo Alto Networks Inc.

PANW

Palo Alto Networks Inc.

HOLD

Current Price

$281.44

Market Cap

212.3B

Sector

Technology

ML Signal

HOLD

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

HOLD

Current Price

$115.09

Market Cap

268.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PANW
MRK
Founded
2005
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3B
268.7B
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
PANW
MRK
Price
$281.44
$115.09
Analyst Decision
Buy
Buy
Analyst Count
39
17
Target Price
$216.28
$125.59
AVG Volume (30 Days)
8.2M
8.4M
Earning Date
05-19-2026
04-30-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
8.01
EPS
0.79
N/A
Revenue
$2,273,100,000.00
$65,011,000,000.00
Revenue This Year
$24.93
$3.61
Revenue Next Year
$19.97
$5.41
P/E Ratio
$354.61
N/A
Revenue Growth
29.04
1.31
52 Week Low
$139.57
$76.66
52 Week High
$302.95
$125.14

Technical Indicators

Market Signals
Indicator
PANW
MRK
Relative Strength Index (RSI) 64.16 46.23
Support Level $179.81 $112.96
Resistance Level $302.95 $123.93
Average True Range (ATR) 13.58 2.93
MACD -2.39 -0.47
Stochastic Oscillator 57.57 18.60

Price Performance

Historical Comparison
PANW
MRK

About PANW Palo Alto Networks Inc.

Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three-fourths of the Global 2000.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: